Last reviewed · How we verify

NCT03980886: EoE

Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)

Recruiting now Last updated 25 November 2024
What this trial tests

trial in Eosinophilic Esophagitis in 1,500 participants. Currently enrolling.

Timeline
11 February 2019
Primary endpoint
17 December 2028
17 December 2028

Quick facts

Lead sponsorUniversity of California, San Diego
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,500
Start date11 February 2019
Primary completion17 December 2028
Estimated completion17 December 2028
Sites1 location across United States

Conditions studied

Sponsor

University of California, San Diego

Who can join

Adults 1 to 65, any sex, with Eosinophilic Esophagitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single center observational and specimen banking study for children with eosinophilic esophagitis EoE to gauge natural history and inflammatory markers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Eosinophilic Esophagitis

Currently open trials in the same condition.

Other University of California, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03980886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing